{
  "ticker": "RAD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969686",
  "id": "02969686",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250716",
  "time": "0901",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lv3hwtxr6bs5.pdf",
  "summary": "- **R&D Tax Refund Received**: A$4.485M (including A$94,559 interest) for FY2024 under Australia's R&D tax incentive.  \n- **Use of Funds**: To support ongoing development of radiopharmaceutical product pipeline.  \n\n*No material capital markets or trading-impacting information identified beyond the refund disclosure.*",
  "usage": {
    "prompt_tokens": 876,
    "completion_tokens": 72,
    "total_tokens": 948,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-15T23:13:08.617870"
}